Blegen Halward Martin John, Plaster Andrew Lemuel, Hobbs Samuel David, Reed Donovan Stephen, Santamaria Joseph Anthony, Heath Zachary George, Nelson Frederick David, Giles Gregory Bryant, Drayna Paul Michael
Brooke Army Medical Center, Fort Sam Houston, TX, USA.
Wilford Hall Ambulatory Surgical Center, Department of Ophthalmology, San Antonio, TX, USA.
J Vitreoretin Dis. 2020 Aug 12;4(6):490-493. doi: 10.1177/2474126420937172. eCollection 2020 Nov-Dec.
Extracorporeal membrane oxygenation (ECMO) is an established treatment modality for critically ill patients with cardiopulmonary failure, yet little is known of the ocular pathology in this population. The aim of this study is to characterize the posterior segment findings of ECMO patients.
This study is a retrospective analysis of 20 ECMO patients evaluated by ophthalmology from September 2012 to May 2019 at a level 1 trauma center. Comprehensive examinations assessed for intraocular pathology. Demographic data, exam findings, and mortality were analyzed.
The sample size consisted of 20 patients; a majority were male (75%), and mean age was 37.4 years (interquartile range, 26.75-50 years). All patients received ECMO for care of acute respiratory distress syndrome (ARDS). Average duration of ECMO therapy was 9.6 ± 6.5 days. Eleven (55%) patients had acute retinal pathology, including Purtscher-like retinopathy (20%), intraocular hemorrhage (50%), and septic chorioretinitis (bacterial or fungal, 10%). Location of hemorrhage included the retina (40%), vitreous (30%), and optic disc (15%). Sixty percent (n = 12) of patients were unable to provide a subjective history on initial assessment. Ultimately, 5 out of 20 patients (25%) died of systemic illness during their hospital stay.
This study demonstrates high rates of retinal pathology, most commonly vitreous and/or retinal hemorrhage alongside a Purtscher-like retinopathy. This is likely secondary to complications of anticoagulation, microthrombi, septicemia, and hemodynamic instability. We found a mortality rate slightly lower than that of prior ECMO studies. Prospective studies with pre-ECMO and post-ECMO fundus photography is warranted for better understanding of these medically complex patients.
体外膜肺氧合(ECMO)是治疗心肺功能衰竭重症患者的一种既定治疗方式,但对于这一人群的眼部病理情况知之甚少。本研究的目的是描述接受ECMO治疗患者的眼后段表现。
本研究是对2012年9月至2019年5月在一家一级创伤中心接受眼科评估的20例ECMO患者进行的回顾性分析。综合检查评估眼内病理情况。分析人口统计学数据、检查结果和死亡率。
样本包括20例患者;大多数为男性(75%),平均年龄为37.4岁(四分位间距为26.75 - 50岁)。所有患者均因急性呼吸窘迫综合征(ARDS)接受ECMO治疗。ECMO治疗的平均持续时间为9.6±6.5天。11例(55%)患者有急性视网膜病变,包括类Purtscher视网膜病变(20%)、眼内出血(50%)和感染性脉络膜视网膜炎(细菌或真菌性,10%)。出血部位包括视网膜(40%)、玻璃体(30%)和视盘(15%)。60%(n = 12)的患者在初次评估时无法提供主观病史。最终,20例患者中有5例(25%)在住院期间死于全身性疾病。
本研究表明视网膜病变发生率很高,最常见的是玻璃体和/或视网膜出血以及类Purtscher视网膜病变。这可能继发于抗凝、微血栓、败血症和血流动力学不稳定等并发症。我们发现死亡率略低于先前的ECMO研究。有必要进行ECMO治疗前和治疗后的眼底摄影前瞻性研究,以更好地了解这些病情复杂的患者。